Portfolio company
Oncoinvent
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
Deep TechDigital Health
About
Oncoinvent develops alpha-emitting radiopharmaceuticals to treat solid cancers, specifically targeting peritoneal metastases in patients after surgery for ovarian or colorectal cancer.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.